By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

WellSpring Pharmaceutical Corporation 

1430 State Highway 34

Neptune  New Jersey  07753-6807  U.S.A.
Phone: 732-938-5885 Fax: 732-751-9056


SEARCH JOBS


Industry
Pharmaceutical






Company News
Prasco Laboratories Announces Agreement With WellSpring Pharmaceutical Corporation for the Authorized Generic of Dibenzyline® 5/1/2013 10:39:28 AM
Ancor Acquires WellSpring Pharmaceutical Corporation 11/7/2011 7:05:53 AM
WellSpring Pharmaceutical Corporation Emetrol(R) Consumer Brand Achieves Number One Position in Anti-Nausea Category 4/21/2009 9:57:22 AM
WellSpring Pharmaceutical Corporation Announces Hire of Wayne Miller as Vice President, Sales & Marketing, Consumer Brands 11/7/2008 7:49:07 AM
WellSpring Pharmaceutical Corporation Names Wendy Shusko as New Chief Operating Officer 10/28/2008 4:08:27 PM
WellSpring Pharmaceutical Corporation Acquires Consumer Product Brands from McNeil Consumer & Specialty Pharmaceuticals (JNJ) 9/2/2008 11:03:58 AM
WellSpring Pharmaceutical Corporation Receives FDA Clearance To Market Duvoid(R) Brand Of Bethanechol 50mg Strength10/19/2005 5:12:36 PM
Medsite's E-Pharma Marketing Gain Share Methodology Increases WellSpring Pharmaceutical Corporation's Dyrenium Prescriptions; Medsite Pharmaceutical Services Offers A Zero Cost, Zero Risk Option For Mature Therapies With Limited Marketing Resources10/19/2005 5:12:26 PM
US Patent And Trademark Office Publishes WellSpring Pharmaceutical Corporation Synthesis Patent For Stanate(R) - New Drug In Late Stage Development For Neonatal Jaundice 10/19/2005 5:12:21 PM
WellSpring Pharmaceutical Corporation And Medsite Pharmaceutical Services, LLC Complete E-Pharma Marketing Agreement To Promote Diuretic Drug, Dyrenium10/19/2005 5:10:16 PM
12
//-->